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LysR-type transcriptional regulators (LTTRs) are the most common family of transcriptional
regulators found in the opportunistic pathogen Pseudomonas aeruginosa. They are known to
regulate a wide variety of virulence determinants and have emerged recently as positive global
regulators of pathogenicity in a broad spectrum of important bacterial pathogens. However, in
spite of their key role in modulating expression of key virulence determinants underpinning
pathogenic traits associated with the process of infection, surprisingly few are found to be
transcriptionally altered by contact with host cells. BvlR (PA14_26880) an LTTR of previously
unknown function, has been shown to be induced in response to host cell contact, and was
therefore investigated for its potential role in virulence. BvlR expression was found to play a pivotal
role in the regulation of acute virulence determinants such as type III secretion system and
exotoxin A production. BvlR also played a key role in P. aeruginosa pathogenicity within the
Caenorhabditis elegans acute model of infection. Loss of BvlR led to an inability to form tight
microcolonies, a key step in biofilm formation in the cystic fibrosis lung, although surface
attachment was increased. Unusually for LTTRs, BvlR was shown to exert its influence through the
transcriptional repression of many genes, including the virulence-associated cupA and alg genes.
This highlights the importance of BvlR as a new virulence regulator in P. aeruginosa with a central
role in modulating key events in the pathogen–host interactome.
INTRODUCTION
Cystic fibrosis (CF) is the most prevalent autosomal
recessive disorder in the Caucasian population. The leading
cause of morbidity among CF patients is loss of lung
function due to chronic bacterial infection (Koch & Hoiby,
1993).While a range of different bacteria establish infections
in the CF lung throughout infancy, many of these are
often treated successfully with antibiotics (Harrison, 2007).
Pseudomonas aeruginosa, however, is capable of avoiding
eradication, and becomes the dominant species of bacteria
in the lungs from the late teens onwards. These chronic
infections result in P. aeruginosa being the leading cause of
morbidity and mortality among CF patients (Lyczak et al.,
2002). To establish a chronic lung infection, P. aeruginosa
utilizes a wide range of virulence determinants, the pro-
duction of which it controls through interconnection of
global and local regulatory networks.
LysR-type transcriptional regulators (LTTRs) are the most
common transcriptional regulators found in Pseudomonas
with 125 putative LTTRs having been identified in the
Pseudomonas genome (Schell, 1993). Several P. aeruginosa
virulence genes have been shown to be under the control
of LTTRs, for example MexT and MvfR, both of which
regulate a range of virulence-associated factors, such
as elastase, phospholipase, homoserine lactone and the
Pseudomonas quinolone signal (Tian et al., 2009; Wade
et al., 2005). The key enzyme in alginate synthesis, AlgD,
has also been shown to be under the control of an LTTR,
CysB (Delic-Attree et al., 1997). As such, LTTRs are rapidly
emerging as a key family of regulators influencing a wide
range of virulence processes in P. aeruginosa (Reen et al.,
2013b).
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In-depth functional analysis of uncharacterized host-
activated LTTRs is necessary to fully elucidate the network
of regulation influencing P. aeruginosa pathogenicity.
Previously, phylogenetic analysis of LTTRs in the genus
Pseudomonas identified several distinct clusters (Reen et al.,
2013a). While the analysis was based solely on amino acid
sequence relationships, a pattern of interconnected regu-
lation or cross-talk was observed. This was particularly
evident in the regulation of pathogenic traits. However,
for the most part these LTTRs were transcriptionally silent
during co-culture experiments with host cells (Frisk et al.,
2004). To identify potential LTTRs that are actively
involved in the host–pathogen interaction, publicly avail-
able transcriptome profiles were interrogated and PA2877
(PA14_26880 homologue in P. aeruginosa clinical isolate
PA14) was shown to be upregulated in response to epithelial
cells (Frisk et al., 2004). To investigate its potential role in
pathogenicity, PA14_26880 was characterized at both the
molecular and the phenotypic level in P. aeruginosa PA14.
This LTTR was found to have a significant influence on
the expression of acute determinants, with mutation of
PA14_26880 leading to enhanced killing of the nematode
acute model of infection. Our data support a role for
PA14_26880 as a key regulator of virulence-associated
phenotypes and pathogenesis in P. aeruginosa.
METHODS
Strains, plasmids and media. The strains and plasmids used in this
study are listed in Table 1. All experiments were performed in wild-
type P. aeruginosa strain UCBPP-PA14 or mutants obtained from the
non-redundant PA14 insertion mutant library – PA14NR Set (Liberati
et al., 2006). All strains were routinely cultured in Luria–Bertani (LB;
Sigma) broth at 37 uC with shaking at 150 r.p.m. unless otherwise
stated. Antibiotics were added to cultures where required at the
following concentrations: Escherichia coli – kanamycin 25 mg ml21,
tetracycline 20 mg ml21, chloramphenicol 20 mg ml21; P. aeruginosa –
tetracycline 25 mg ml21, gentamicin 20 mg ml21, streptomycin
100 mg ml21.
Table 1. Strains/plasmids used in this study
Name Description Reference/source
Plasmids
pMP190 IncQ origin, low-copy-number lacZ fusionvector; CmR StR Spaink et al. (1987)
pMP190_exsC Contains promoter region of exsC cloned into MCS This study
pME6032 pVS1-p15A origin, lacIq-Ptac expression vector, TcR Heeb et al. (2000)
pMEbvlR pME6032 plasmid with bvlR(PA14_26880) gene cloned into MCS This study
pMS402 Promoterless lux operon downstream of MCS, TmR Duan & Surette (2007)
pMS-bvlRp Contains promoter region of bvlR cloned into MCS This study
pRK600 Mobilization plasmid helper Keen et al. (1988)
pCR2.1-TOPO PCR cloning vector, ApR KmR Invitrogen
pET28a T7 promoter-driven His-tag protein expression vector, KmR Novagen
pET28abvlRCter C-terminal His-tagged bvlR in pET28a This study
Strains
PA14 pME6032 Wild-type PA14, P. aeruginosa clinical isolate, containing empty plasmid pME6032 This study
PA14 : : bvlR pME6032 PA14 with Tn5 Mariner Transposon in bvlR, containing empty plasmid pME6032 This study
PA14 : : bvlR pMEbvlR PA14 with Tn5 Mariner Transposon in bvlR ORF, pME6032 plasmid with bvlR
gene cloned into MCS
This study
PA14 pMSbvlR PA14, containing pMS plasmid with bvlR promoter cloned into MCS This study
PA14 : : bvlR pMS PA14 with Tn5 Mariner Transposon in bvlR, containing empty plasmid pMS This study
PA14 : : bvlR pMS-bvlRp PA14 with Tn5 Mariner Transposon in bvlR, containing pMS plasmid with bvlR
promoter cloned into MCS
This study
PA14 pME6032
pMP190_exsC
Previously described strain containing pMP190_exsC This study
PA14 : : bvlR pME6032
pMP190_exsC
Previously described strain containing pMP190_exsC This study
PA14 : : bvlR pMEbvlR
pMP190_exsC
Previously described strain containing pMP190_exsC This study
PA14 : : bvlA Wild-type PA14 with Tn5 Mariner Transposon in bvlA ORF Liberati et al. (2006)
E. coli HB101 Cloning and subcloning host Sambrook & Russell (2001)
E. coli Top10 Cloning and subcloning host Invitrogen
E. coli DH5a Cloning and subcloning host Boyer & Roulland-Dussoix
(1969)
E. coli OP50 Caenorhabditis elegans non-toxic strain Blier et al. (2011)
BL21-CodonPlus
BL21(DE3)-RIPL
Protein expression host Merck
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Generation of plasmids used in this study. All PCRs were
performed in a final volume of 20 ml using Pfu Proofreading
polymerase (Promega) according to the manufacturer’s recommen-
dations. Primers were designed based on the PA14 genome sequence
(NC_008463) and can be found in Table S1 (available in the online
Supplementary Material). The PCR products were then A-tailed using
100 mM dATP (Applied Bioscience) and AccuPrime polymerase
(Roche Applied Science) and incubated at 94 uC for 2 min followed
by 68 uC for 20 min, after which the PCR products were cloned into
pCR2.1-TOPO (Invitrogen) according to the manufacturer’s recom-
mendations. All constructs were verified by sequence analysis (GATC
Biotech), and subsequently cloned into their respective host plasmids
and finally transferred from E. coli DH5a (Boyer & Roulland-Dussoix,
1969) to P. aeruginosa by triparental mating using the helper plasmid
pRK600 as described by de Lorenzo & Timmis (1994) and Keen et al.
(1988).The T4 DNA ligase and all restriction enzymes used in this
study were purchased from Roche Applied Sciences and were used
according to the manufacturer’s recommendations.
To generate plasmid pMEbvlR, the PA14_26880 ORF was amplified
using primers bvlR OEF and bvlR OER, which contain incorporated
BglII and KpnI restriction sites, respectively, and was ligated into the
pME6032 multiple cloning site (MCS) downstream of the Ptac
promoter (Heeb et al., 2000). The vector was then transformed by
heat shock into E. coli Top10 Cloning and subcloning host (Invitrogen).
To generate an exsC promoter expression construct, a 340 bp fragment
upstream of exsC was amplified with exsC TFF and exsC TFR, which
incorporated the XbaI and KpnI restriction sites, respectively. The
XbaI–KpnI exsC fragment was cloned into XbaI–KpnI-digested
pMP190 (Spaink et al., 1987) to produce pMP190_exsC.
To construct a plasmid expressing a His-tagged BvlR protein, the
bvlR ORF was amplified using primers BvlR His F and BvlR His R,
which incorporate NcoI and HindIII restriction sites, respectively.
Finally, the amplicon was cloned into the MCS of pET28a to yield
pET28abvlRH6C, which expressed a C-terminal His-tagged BvlR
protein.
Transcriptional fusions to luxCDABE were generated by cloning the
promoter regions of PA14_26880, amplified by PCR using primer sets
bvlR TFF and BvlR TFR. The amplicon was flanked by XhoI–BamHI
restriction sites, allowing it to be ligated into the sites XhoI–BamHI of
pMS402 (Duan & Surette, 2007). Luminescence was measured over
time using a Tecan GENios Microplate Reader.
b-Galactosidase assay. For the b-galactosidase assay, P. aeruginosa
cultures were grown overnight in LB broth supplemented with
appropriate antibiotics. IPTG was added at a concentration of 1 mM
for all pME6032 derivative plasmids. Cells were diluted to an OD600
of 0.05 in 20 ml and incubated at 37 uC at 150 r.p.m. Cells were
recovered at the exponential phase of growth and b-galactosidase
assays were performed as described by Miller (1972). Data are the
mean of three independent biological replicates.
Microcolony formation assay. Artificial sputum medium (ASM)
was prepared as described by Sriramulu et al. (2005). ASM (1 ml) was
inoculated to an OD600 of 0.05 with an overnight culture of P.
aeruginosa PA14 in 24-well cell-culture plates (Sarstedt). IPTG
was added at a concentration of 1 mM for all pME6032 derivative
plasmids. Plates were then incubated at 37 uC at 150 r.p.m. for
72 h. Three independent biological replicates were performed, and
representative results are shown.
Caenorhabditis elegans assays. The C. elegans assay was
performed as described by Blier et al. (2011). In brief, C. elegans
was maintained under standard culturing conditions at 22 uC on
nematode growth medium (all per litre, 3 g NaCl, 2.5 g peptone, 17 g
agar, 5 mg cholesterol, 1 ml 1 M CaCl2, 1 ml 1 M MgSO4, 25 ml 1 M
KH2PO4) agar plates with E. coli OP50 as a food source (Sulston
& Hodgkin, 1988). Synchronous cultures of worms were generated.
Pathogen lawns used for C. elegans survival assays were prepared by
spreading 50 ml P. aeruginosa strains corrected to an OD600 of 1
(mutant vs. complemented). The plates were incubated overnight at
37 uC and then placed at room temperature for 4 h. Between 15 and
20 L4 synchronized worms were harvested with M9 solution, placed
on 35 mm assay Petri dishes and incubated at 22 uC. Worm survival
was scored at 1 h, 24 h and each subsequent day, using an Axiovert
S100 optical microscope (Zeiss) equipped with a Nikon digital camera
DXM 1200F (Nikon Instruments). The worms were considered dead
when they remained static without grinder movements for 20 s.
Standard ethical procedures were used. The results are expressed as
the percentage of living worms and are the mean of three independent
biological assays.
Attachment assay. Due to the viscous nature of ASM, it was
not feasible to accurately determine levels of bacterial attachment in
this medium. Therefore, M63 medium was prepared as described by
O’Toole & Kolter (1998) and used to assess bacterial attachment.
Strains were inoculated from a fresh overnight culture into 1 ml of
M63 broth in 24-well microtitre plates (Starstedt) at an OD600 of 0.25.
IPTG was added to the medium at a concentration of 1 mM. Cultures
were incubated at 37 uC for 1 h statically. OD600 was measured to
ensure no difference in growth. Cultures were removed and wells
washed three times with 1.2 ml LB. Then, 1.3 ml of 0.1% crystal
violet (Sigma) was added and incubated at room temperature for
10 min. The crystal violet was removed and the wells were washed five
times with distilled H2O. Plates were then dried at 37 uC for 2 h.
Then, 1.5 ml of 96% EtOH was added to each well and incubated at
room temperature for 15 min. One hundred microlitres was then
taken from each well and added to a clean 96-well plate (Corning)
and OD570 was measured.
Flow cell biofilm assay. Flow cell chambers with individual
channel dimensions of 164640 mm were used. The flow system
was assembled and prepared as described by Gjermansen et al. (2005).
Overnight cultures of Pseudomonas strains were inoculated as single
colonies into 5 ml of M63 medium (O’Toole & Kolter (1998) and
shaken (180 r.p.m.) overnight at 37 uC. Bacteria were grown in M63
medium throughout the flow cell experiment. The flow chambers
were inoculated by injecting 250 ml overnight culture diluted to
an OD600 of 1 into each flow channel using a small syringe. After
inoculation, the flow channels were left without flow for 1 h, after
which medium flow was started using a Watson Marlow 205S
peristaltic pump. The mean flow velocity in the flow chambers was
0.2 mm s–1, corresponding to a laminar flow with a Reynolds number
of 0.02. The flow cell biofilm system was incubated at 30 uC
throughout the experiment. Bacteria were stained using 5 mM SYTO 9
(Invitrogen). Visualization of the biofilm was performed using a Zeiss
LSM5 confocal laser scanning microscope equipped with the 488 nm
laser lines to excite SYTO 9. Three independent biological replicates
were performed. Images were processed using the Imaris 6.0.2
Software suite.
RNA isolation, global expression analysis, cDNA synthesis and
quantitative real-time PCR. RNA was extracted from exponential-
phase cultures (OD600 of 0.7–0.8) of PA14 pME6032, PA14 : : bvlR
pME6032 and PA14 : : bvlR pME6032_bvlR using the RNeasy minikit
(Qiagen). Genomic DNA was removed using TURBO DNase
(Ambion). Isolated RNA was sent to DNAVision for further analysis.
RNA quality was assessed using a Bioanalyser Agilent 2100 at
DNAVision. cDNA synthesis, fragmentation and terminal labelling
preceded hybridization on Affymetrix GeneChip P. aeruginosa genome
arrays according to the Affymetrix guidelines. GeneSpring GX software
was used to analyse raw data following the manufacturer’s guidelines.
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In brief, the raw data were normalized using the robust multiarray
average algorithm. An empirical Bayesian unpaired comparison
(moderated t-test, P,0.05) was carried out to generate a list of genes
with significantly altered expression between the test strains of greater
than twofold.
For quantitative real-time PCR analysis, cDNA was synthesized
using AMV reverse transcriptase (Promega) and random primers
(Invitrogen). Real-time primers were designed utilizing the Universal
Probe Library Assay Design Center (UPL, Roche). Real-time PCR
was conducted on a Chromo4 Continuous Fluorescence Detector
(MJ Research) using FastStart TaqMAN Probe Master and probes
from the Universal ProbeLibrary (UPL, Roche) according to the
manufacturer’s recommendations. All data presented are relative to
the housekeeping gene proC, and are the mean of three independent
biological replicates.
His-tag purification of BvlR. The pET28abvlRH6C construct
was transformed into the E. coli expression host strain BL21-
CodonPlus BL21(DE3)-RIPL (Merck) and grown at 37 uC with
shaking at 150 r.p.m. in 250 ml LB medium containing kanamycin
(50 mg ml21) until an OD600 of 0.8 was reached. At this point 1 mM
IPTG was added to the culture to induce expression of the His-tagged
BvlR protein. After 4 h, cells were harvested by centrifugation at 5000 g
at 4 uC and stored at270 uC overnight. Cell pellets were subsequently
thawed and resuspended in CelLytic B II buffer (10 ml per gram of cell
paste) with 50 units benzonase ml21, 0.2 mg lysozymeml21 and 100 ml
of Protease Inhibitor Cocktail (all concentrations relative to 1 g of cell
paste). Protein extract was applied to a Poly-4 Prep Chromatography
Column (Bio-Rad) containing 1 ml of HIS-Select Nickel Affinity
Gel. The gel was washed with 2 ml of sterile de-ionized water and
equilibrated with 5 ml of wash buffer (100 mM HEPES, pH 7.5,
10 mM imidazole). Following washing and equilibration steps,
the crude protein extract (10 ml) was passed through the column by
gravity flow. Proteins which bound to the resin were washed twice with
5 ml wash buffer and purified His-tagged BvlR protein was eluted in
wash buffer containing imidazole at the following concentrations
(1, 10, 50, 100, 250, 500 and 750 mM). The purity of the purified
BvlR protein was assessed by SDS PAGE as described by Sambrook
& Russell (2001). Protein concentrations were determined by the
Bio-Rad protein assay (Bradford, 1976) and purified protein aliquots
were used for electromobility shift assays (EMSAs). All chemicals were
purchased from Sigma Aldrich unless stated otherwise.
EMSA. First, the labelled promoter DNA fragments were generated
by amplification of the promoter fragments with infrared-labelled
primers (Eurofins MWG Operon) (Table 1) using Pfu Proofreading
polymerase (Promega), according to the manufacturer’s recommen-
dations in a total volume of 20 ml. Amplified DNA fragments were
visualized by agarose gel electrophoresis and subsequently purified
using a gel extraction kit (Qiagen), according to the manufacturer’s
recommendations. The bvlR/bvlA IRF and bvlR/bvlA IRR primer set
was used to construct the blvA–bvlR intergenic region, whereas the
truncated blvA–bvlR intergenic region was amplified using bvlR/bvlA
IT IRF and bvlR/bvlA IT IRR primers. The oprF–sigX intergenic
region was amplified using the primers OprF IRF and OprF IRR. The
primer sets use to amplify other promoter regions included in this
study are presented in Table S1 The final EMSA reaction volume was
20 ml, containing varying concentrations of purified BvlR protein
(50–2000 nM) in the presence of 10 fmol of labelled promoter DNA
fragment in EMSA binding buffer [20 mM HEPES, pH 7.6, contain-
ing 30 mM KCl, 5 mM (NH4)2SO4, 1 mM EDTA, 1 mM DTT, 0.2%
(w/v) Tween 20 and 5 mg poly[d(I-C)] ml21]. The reaction was
incubated at 28 uC for 40 min, and samples were then separated by
electrophoresis on 6% (v/v) native polyacrylamide gel and visualized
on an Odyssey Infrared Imaging System (Li-COR Biosciences).
Control binding reactions were performed with extracts from E. coli
BL21-CodonPlus BL21(DE3)-RIPL cells harbouring the pET28a
vector control.
Bioinformatic analysis.DNA sequence was obtained from the PA14
genome sequence (NC_008463) and used as bait in sequential BLASTN
and BLASTP searches. Potential BvlR binding motifs were identified
using the DNA Motif Search tool at www.pseudomonas.com. All
amino acid sequences were aligned with CLUSTAL W and phylogenetic
analysis was performed using the MEGA5 software program. Trees
were generated using the neighbour-joining algorithm (p-Distance)
using as outgroup P. aeruginosa PA2206, a non-homologous LTTR.
Minimum bootstrap support values ¢95% were enforced for this
analysis.
Statistical analysis. For the C. elegans assay, survival was calculated
by using the Kaplan–Meier method, and survival differences were
tested for significance by using the log-rank test (GraphPad Prism
version 4.0, GraphPad Software) over three independent biological
replicates. For all other experiments outlined here, statistical analysis
was performed using a two-tailed paired Student’s t-test. Differences
were considered significant if the P-value was ¡0.05 over three
independent biological replicates.
RESULTS
A new repressor (PA14_26880) of the type III
secretion system
The process of infection by P. aeruginosa is primarily
characterized by two distinct phases. Initial colonization
through expression of acute virulence determinants is
followed by a switch to a chronic biofilm state that is
practically impossible to eradicate. The involvement of
LTTRs in this process remains poorly understood in spite of
the fact that they represent the largest family of transcrip-
tional regulators in P. aeruginosa. Analysis of the publicly
available transcriptome datasets revealed that PA2877
(PA14_26880 homologue in P. aeruginosa clinical isolate
PA14) is transcriptionally altered in response to epithelial
cell contact, suggesting that it may play a role in P.
aeruginosa pathogenicity. Transcriptional analysis was used
to determine if PA14_26880 exerted a regulatory influence
over the acute-associated type III secretion system (T3SS).
The promoter region of the exsCDBA operon, containing
the T3SS master regulator ExsA, was cloned upstream
of a promoterless lacZ gene into pMP190, resulting in
pMP190_exsC. b-Galactosidase assays verified that T3S
was elevated 1.7-fold (Student’s t-test, P,0.05) in the
PA14_26880 transposon mutant derived from the non-
redundant PA14 insertion mutant library (Liberati et al.,
2006) (Fig. 1a). This elevated transcription was restored
to wild-type levels through complementation with the
PA14_26880 ORF cloned into the inducible plasmid
pME6032 (Fig. 1a).
PA14_26880 promotes tight microcolony
formation
Having established a role for PA14_26880 in the regulation
of T3S, the possibility that this transcriptional regulator
bvlR, a new virulence regulator
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might also modulate biofilm formation was subsequently
investigated. Biofilm formation and T3S have previously
been shown to be inversely regulated, although the
mechanism underpinning this observation has not been
fully elucidated (Furukawa et al., 2006). P. aeruginosa has
been shown to form a tight microcolony in the CF lung. This
behaviour differs from the classical definition of a biofilm as
surface attachment is not required (Sriramulu et al., 2005;
Worlitzsch et al., 2002). The influence of PA14_26880 on
this host-specific mode of biofilm formation was assessed in
a synthetic medium that mimics the sputum found in the
CF lung (Sriramulu et al., 2005). A PA14_26880 transposon
mutant was unable to form tight microcolonies in this ASM.
Complementation with pMEbvlR restored the ability of
a PA14_26880 mutant to form tight microcolonies. These
data suggest that PA14_26880 is integral to the formation
of non-surface-attached biofilms such as those found in the
CF lung (Fig. 1b). Interestingly, the PA14_26880 mutant
exhibited increased levels of abiotic surface attachment,
which was restored to wild-type levels through comple-
mentation (Fig. 1c). Flow cell biofilm analysis confirmed the
hyperattachment phenotype associated with a PA14_26880
mutant (Fig. 1d). Assays of extracellular matrix components
such as rhamnolipid and extracellular DNA (data not
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Fig. 1. (a) Elevated levels of T3S in a PA14_26880 mutant. Expression from pMP190_exsC in PA14 pME6032,
PA14 : :PA14_26880 pME6032 and PA14 : :PA14_26880 pME PA14_26880 was assessed by performing b-galactosidase
assays on cells that were recovered at the exponential phase of growth. Fold change is relative to wild-type levels. All
measurements are in Miller units. Data shown are mean values of three biological experiments with SD as error bars. *Student’s
t-test, P , 0.05. (b) PA14_26880 has a role in tight microcolony formation. Tight microcolony formation was assessed by
growing strains in ASM for 72 h in 24-well plates. Tight microcolony formation is seen as dark non-surface-attached
aggregates, which are highlighted by a white arrow. These tight microcolonies project up into the well but are not attached to
any surface. Complete loss of tight microcolony formation is observed in PA14 : :PA14_26880 pME6032. The image shown is
a representative of at least three independent biological replicates. (c) PA14_26880 plays a role in attachment. Levels of bacterial
attachment were assessed using a crystal violet staining assay. Increased levels of attachment observed in PA14 : :PA14_26880
pME6032. *Student’s t-test, P , 0.05. (d) PA14_26880 plays a role in attachment. To confirm the hyperattachment phenotype
observed in the crystal violet assay and to ensure that this was not due to increased production of components of the biofilm
matrix, flow cell biofilm analysis was performed. This analysis confirmed that a PA14_26880 mutant indeed attaches to an abiotic
surface at a much higher level than wild-type cells. Images were taken after 24 h of incubation. Cells were stained with the DNA-
specific SYTO9 dye. Images were processed using the Imaris 6.0.2 Software suite. Bars, 15 mm.
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shown) were performed and demonstrated no difference
between the wild-type and mutant, suggesting that this
increased attachment is not due to an alteration in the
production of biofilm matrix components. This increased
attachment phenotype is consistent with the PA14_26880
mutant cells being unable to self-aggregate in a tight
microcolony. The negative regulation of T3SS and pro-
motion of tight microcolony formation by PA14_26880
suggests a role in the chronic phase of P. aeruginosa
infection within the host. Given the role of PA14_26880 in
these key virulence phenotypes it is hereafter referred to as
BvlR (Biofilm and Virulence LysR Regulator).
BvlR plays a key role in virulence in the C. elegans
model of infection
Having established that BvlR plays a role in the modulation
of key virulence determinants, it was hypothesized that it
may play a role in the overall pathogenic potential of
P. aeruginosa. To investigate this, the nematode model of
infection C. elegans was utilized. To ensure isogenicity,
the bvlR mutant was compared with the complemented
pMEbvlR strain. The presence of BvlR led to a significant
reduction in virulence at each time point (Student’s t-test,
P,0.01) (Fig. 2), suggesting a significant role in P. aeruginosa
pathogenesis. Therefore, BvlR was functionally characterized
to elucidate the molecular mechanisms underlying this key
role in pathogenicity.
BvlR negatively regulates the expression of a
divergent gene bvlA and auto-regulates its own
expression
To identify the pathway(s) through which BvlR mediates
expression of virulence determinants in P. aeruginosa, it
was first decided to assess if BvlR fulfilled the expected
molecular characteristics associated with a ‘classical’ LTTR.
LTTRs are typically capable of negative auto-regulation
and positively influence the transcription of divergently
transcribed genes in close genomic proximity. These
divergently transcribed targets are often responsible for
the LTTRs, effect on virulence (Maddocks & Oyston, 2008;
Schell, 1993). To investigate whether BvlR was capable of
auto-regulation, the promoter region of bvlR was cloned
into a plasmid, pMS402, which contains a promoterless
2lux fusion. In a bvlR mutant expression of bvlR was
significantly higher (Student’s t-test, P,0.05) than that
observed in the wild-type over an 8 h time period (Fig. 3a),
indicating that bvlR was capable of auto-regulation.
Divergently upstream from bvlR is PA14_26870 (bvlA), a
gene assigned a hypothetical function. Bioinformatic analysis
showed that bvlR and bvlA gene synteny is conserved in other
Pseudomonas species. Moreover, a high degree of conser-
vation is observed in the intergenic region between bvlR and
bvlA, indicating that regulatory elements of significance may
be present within this region. Quantitative real-time PCR
was used to demonstrate that BvlR exerted a strong negative
regulatory influence over bvlA (Student’s t-test, P,0.05)
(Fig. 3b). The negative influence of BvlR on the expression of
bvlA is contrary to the observed regulatory features typically
assigned to an LTTR. This evidence suggests that BvlR may
be an LTTR that functions predominantly as a transcrip-
tional repressor, few of which have previously been described
(Maddocks & Oyston, 2008).
BvlR exerts its regulatory influence over bvlA
through direct binding to the bvlR–bvlA intergenic
region
Typically LTTRs exhibit their regulatory influence over
a divergently transcribed gene through direct binding
(Maddocks & Oyston, 2008). A His-tagged BvlR expression
construct was generated (pET28abvlRH6C) and the BvlR
regulator was subsequently purified as a monomer of
34.5 kDa by nickel affinity column chromatography (Fig.
S1). An EMSA was performed to assess if the transcriptional
influence that BvlR was exerting over bvlA was due to direct
binding. Purified His-tagged BvlR fusion protein caused
a mobility shift in the presence of an infrared-labelled
DNA probe spanning the bvlR–bvlA intergenic region
(Fig. 4b). These data demonstrate that BvlR is binding
to the bvlR–bvlA intergenic region. As LTTRs typically
bind a specific motif, T-N11-A, the bvlR–bvlA intergenic
region was analysed for such a motif. A single T-N11-A
(TCCCGAATAGAGA) motif was identified in the bvlR–
bvlA intergenic region (Fig. 4a). To investigate if this motif
was essential for direct binding, EMSA was performed using
a truncated bvlR–bvlA intergenic region, amplified using the
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primer set bvlR/bvlA IT IRF and bvlR/bvlA IT IRR, which
did not contain this potential binding site. The purified His-
tagged BvlR fusion protein did not cause a mobility shift in
the presence of this amplicon encompassing the sequence
from 231 to 2249 bp downstream of the bvlA transcrip-
tional start site (Fig. 4c), demonstrating that BvlR binding
requires the TCCCGAATAGAGA motif. As BvlR and BvlA
are divergently transcribed the bvlR–bvlA intergenic region
encompasses the promoter regions of both genes. Thus, the
directing binding to this intergenic region is likely to be not
only responsible for the effect of BvlR on bvlA transcription
but also for the auto-regulation of bvlR expression. As bvlA
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Fig. 3. (a) BvlR regulates bvlA expression levels. Quantitative real-time PCR was performed using primers specific to bvlA. Fold
change in presented relative to the housekeeping gene proC. *Student’s t-test, P , 0.05. (b) BvlR demonstrates negative auto-
regulation. Expression of bvlR over time measured in relative light units using a modified pMS402 that contains a bvlR
promoter–lux fusion conjugated to PA14 pME6032 and PA14 : :bvlR pME6032. All light readings were made relative to optical
density. The data are the mean of three independent biological replicates.
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is a direct transcriptional target of BvlR it could be
responsible for the phenotypes associated with a bvlR
mutant. However, a bvlA mutant failed to influence T3S,
attachment or tight microcolony formation, indicating that
bvlA is not responsible for the BvlR-associated phenotypes
identified in this study (data not shown). That BvlA does
not appear to play a role in any of the identified BvlR
phenotypes suggests that other targets of BvlR may be
responsible for the observed phenotypes, consistent with
the emerging role of LTTRs as global regulators of gene
expression.
BvlR regulation controls virulence-associated
gene expression
To identify other transcriptional targets of BvlR that could
explain the observed phenotypes, global transcriptomic
analysis was performed. To ensure isogenicity, the bvlR
mutant was compared with the complemented strain for
transcriptomic analysis. Approximately 5.6% of the genes
(307 genes of the 5500 P. aeruginosa PAO1 probe sets on
the microarray) demonstrated significantly altered expres-
sion greater than twofold (moderated t-test, P,0.05) (Table
S2). The changes in gene expression ranged from 210.6- to
22-fold. BvlR negatively influenced the expression of all of
the genes in the transcriptome dataset, further emphasizing
BvlR’s potential role as a transcriptional repressor. A
number of genes associated with virulence were repressed
by BvlR (Table 2), confirming the influence of BvlR on the
pathogenicity of P. aeruginosa. Genes involved in metabolite
transportation were also highly represented within the
transcriptome dataset. To establish further the role of
BvlR, the transcriptome profile was investigated for links
between the changes in gene expression and bvlR-associated
virulence phenotypes.
BvlR modulates expression genes associated with
surface attachment. Expression of key genes of the cupA
operon was induced in the bvlR mutant. The cupA operon
encodes components and assembly factors of a fimbrial
structure that are known to play a key role in surface
attachment. It has been shown that increased expression
of this operon can lead to a hyperattachment phenotype
(Kulasekara et al., 2005; Meissner et al., 2007; Vallet et al.,
2001). This corresponds with the increased attachment
observed in a bvlR mutant. Quantitative real-time PCR
analysis of cupA2 and cupA3 confirmed the initial finding
of the transcriptome dataset that the cupA operon was
indeed upregulated in a bvlR mutant (Fig. 5a). It is thought
that expression of the cup operon is specific to particular
niches such as attachment to specific biological surfaces
(Kuehn et al., 1992). A number of genes associated
with alginate biosynthesis were also modulated in the
transcriptome. This finding was confirmed by quantitative
real-time PCR using primers specific to algK (Fig. 5b).
It is known that alginate is capable of modulating
biofilm architecture, although it is not essential for
biofilm formation (Lizewski et al., 2004). Attachment to a
substratum has been shown to induce expression of genes in
the alginate biosynthetic pathway (Boyd & Chakrabarty,
1994). Based on the influence of surface attachment on
alginate expression, the increased expression of key genes in
Table 2. Virulence genes negatively regulated greater than twofold by BvlR identified through microarray analysis (moderated t-test,
P,0.05)
ORF ID Gene name Description Fold change
Genes associated with attachment and biofilm
PA3541 alg8 Alginate biosynthesis protein 2.5
PA3548 algI Alginate O-acetyltransferase 2.1
PA3549 algJ Alginate O-acetyltransferase 2.0
PA3543 algK Alginate biosynthetic protein 10.6
PA3547 algL Poly(b-D-mannuronate) lyase precursor 2.1
PA2129 cupA2 Chaperone 2.2
PA2132 cupA5 Chaperone 2.4
PA4084 cupB3 Usher 7.2
PA4083 cupB4 Chaperone 2.6
PA4082 cupB5 Adhesive protein 4.1
PA4081 cupB6 Fimbrial subunit 3.2
PA2235 pslE Exopolysaccharide biosynthesis 2.3
PA2236 pslF Exopolysaccharide biosynthesis 2.4
Genes associated with virulence
PA4813 lipC Lipase 8.4
PA3319 plcN Non-haemolytic phospholipase C precursor 2.6
PAO843 plcR Phospholipase accessory protein 2.0
PA1148 toxA Exotoxin A precursor 2.4
PAO707 toxR Transcriptional regulator 2.4
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the alginate biosynthetic operon in the bvlR mutant may be
a result of the increased surface attachment associated with
the bvlR mutant.
BvlR negatively regulates exotoxin A expression.
BvlR expression also modulated toxA expression in the
transcriptome dataset. Exotoxin A (toxA) represents one of
the key virulence factors through which P. aeruginosa is
capable of killing C. elegans (Fogle et al., 2002; Matsumoto
et al., 1999). ToxA is an ADP-ribosyltransferase that can
inhibit protein synthesis (Iglewski & Kabat, 1975). Various
animal models have demonstrated the importance of
exotoxin A in P. aeruginosa infection, with toxA mutants
typically being less virulent than their wild-type counterparts
(Fogle et al., 2002; Matsumoto et al., 1999). To validate the
transcriptome results, expression levels of exotoxin A were
determined using quantitative real-time PCR analysis. A
14-fold reduction in toxA levels was observed when BvlR is
present (Student’s t-test, P,0.05) (Fig. 5c). The observed
effect of BvlR on pathogenicity in the C. elegans model is
probably mediated through the reduction in exotoxin A
levels. The positive regulator of exotoxin A, ToxR, was also
found to be downregulated twofold in the transcriptome
dataset, suggesting that BvlR regulatory influence over
toxA may occur through cross-talk between these distinct
transcriptional regulators.
The transcriptome dataset highlights a network of genes
that are transcriptionally repressed by BvlR. Although this
further supports the evidence that bvlR encodes an LTTR
repressor that is capable of downregulating genes asso-
ciated with acute virulence, while promoting the formation
of the self-aggregating tight microcolonies of a mucoid CF
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Expression of key genes in the cupA operon was assessed using quantitative real-time PCR. Primers specific to cupA2 and cupA3
demonstrated a significant repression of operon expression when bvlR is expressed (Student’s t-test, P,0.05). (b) BvlR modulates
algK transcription. Quantitative real-time PCRwas used to determine that expression of algK is reduced sixfold when an active copy
of bvlR is expressed (Student’s t-test, P,0.05). (c) BvlR negatively regulates toxA expression. Quantitative real-time PCR analysis
of exotoxin A production demonstrates that expression of bvlR leads to a 14-fold reduction in toxA transcript levels (Student’s t-test,
P,0.05). RNA was extracted from exponential-phase cultures. All values are presented relative to the housekeeping gene proC.
Data shown are mean values of three biological experiments with SD as error bars. *Student’s t-test, P , 0.05.
R. R. McCarthy and others
1496 Microbiology 160
lung, the molecular interactions underpinning this regu-
lation need to be established.
BvlR role in virulence may be both direct and
indirect
To determine the pathway through which BvlR exerts its
effects on gene expression linked to virulence, candidate
promoters were examined for binding affinity with purified
BvlR protein. A dual approach was taken to the selection
of these promoters, focusing on (a) virulence-associated
genes from the transcriptome profiling and on (b)
those with highly similar T-N11-A motifs to the BvlR
box. Bioinformatic analysis of the P. aeruginosa genome
sequence failed to identify complete BvlR binding motifs,
other than that in the bvlR–bvlA intergenic region.
By systematically reducing the stringency to allow for
mismatches, a bank of potential BvlR binding candidates
was generated, which included intergenic regions upstream
of virulence-associated genes such as exsC, oprF and algQ
(Fig. S2). In addition, several promoters in which motifs
closely related to the BvlR motif were identified were also
included in this analysis, although these loci were not
present in the transcriptome dataset.
Infrared primers were designed to each of the regions that
contained a partial BvlR binding motif. These regions were
then amplified and EMSA binding analysis was performed
(Fig. S3). Purified BvlR was seen to cause a mobility shift
for one of the potential binding targets, the sigX–oprF
intergenic region (Fig. 4d). The BvlR binding motif in
this sigX–oprF intergenic region had among the highest
sequence similarity of all the potential candidates, with 11
of the 13 bases being conserved with the BvlR binding
motif in the bvlR–bvlA intergenic region. While this might
suggest that the interaction of purified BvlR protein with
DNA is highly specific in the absence of a recognized ligand,
it must be noted that other promoters with the same degree
of conservation did not bind BvlR (Fig. S3). Perhaps
surprisingly, although consistent with the transcriptome
profiling, no significant difference in oprF transcription
levels was observed between PA14 pME6032, PA14 : : bvlR
pME6032 and PA14 : : bvlR pMEbvlR in LB broth (data not
shown).
Apart from the sigX–oprF promoter region, BvlR was not
found to interact with the other promoters tested in this
study, even though several contained highly similar motifs
to that in the bvlR–bvlA intergenic region to which BvlR
has been shown to bind. These include the promoters of
several virulence-associated genes which were altered in the
transcriptome profile, suggesting that at least some of the
effects attributed to BvlR may be the result of indirect
regulation. Notwithstanding this, it is well known that the
DNA binding specificity and transcriptional influence of
many LTTRs are significantly altered by the presence of a
specific ligand (Maddocks & Oyston, 2008). The strong
phenotypic profile associated with a BvlR mutant suggests
that BvlR’s direct binding targets are indeed likely to
extend beyond those confirmed in vitro. Future work
will focus on the identification of a specific ligand which
may be central to the interaction of BvlR with direct
transcriptional targets.
DISCUSSION
The data presented demonstrate that the LTTR BvlR is a
novel virulence regulator that plays a key modulatory role
in the expression of a wide range of virulence determinants.
BvlR is one of the few LTTRs whose regulation is altered in
response to eukaryotic cells (Frisk et al., 2004), indicating
a potential role for BvlR in pathogenicity. P. aeruginosa
infection is characterized by two distinct phases, the
acute state and chronic state. Acute infection involves the
production of a wide range of virulence determinants and
a motile mode of growth. BvlR expression was shown
to repress the T3SS, one of the main exotoxin secretion
systems associated with acute infection (Jin et al., 2011;
Mulcahy et al., 2006; Yahr et al., 1995; Yahr & Wolfgang,
2006). Whereas the T3SS was induced in a bvlRmutant, the
ability of the mutant to form tight microcolonies was lost.
This is not surprising as the T3SS and biofilm formation
are often inversely regulated (Furukawa et al., 2006).
Tight microcolony formation is a configuration of biofilm
formation associated with the CF lung. This mode of
biofilm formation differs from typical biofilm formation
as it does not require a surface to attach to. Instead, cells
self-aggregate to form free-floating biofilm-like structures.
Tight microcolony formation is particularly relevant to the
CF lung as it has been shown that 95% of P. aeruginosa
found in the CF lung are present at a distance greater than
5 mm from the epithelial cell surface in non-surface-attached
tight microcolonies (Worlitzsch et al., 2002). The tight
microcolony form of biofilm formation may have very
different phenotypic and genetic properties from the
classically studied surface-attached biofilm. The influence
of BvlR on this phenotype is probably mediated through its
role in repressing cupA-associated fimbrial-based surface
attachment (Lizewski et al., 2004; Mulcahy & Lewenza, 2011;
Vallet et al., 2001). Surface attachment is upregulated in a
bvlRmutant most likely through the increased transcription
of the cupA operon. While fimbrial attachment is key to the
initial stages of biofilm formation on a surface, it has been
shown to be downregulated as the biofilm formation process
proceeds (Lizewski et al., 2004; Mulcahy & Lewenza, 2011;
Vallet et al., 2001). The identification of BvlR as a regulator
of this form of biofilm adds another novel gene to the
complex regulatory network already involved in controlling
biofilm formation. BvlR is the first LTTR to be described
with a role in tight microcolony formation.
Experiments with the C. elegans model of infection demon-
strated that the presence of BvlR reduces the capacity of
P. aeruginosa to establish acute infection. BvlR was shown to
significantly reduce toxA expression, one of the key virulence
determinants through which P. aeruginosa is capable of
bvlR, a new virulence regulator
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killing C. elegans (Fogle et al., 2002; Matsumoto et al., 1999).
Furthermore, the identification of homologues of BvlR
in a wide variety of respiratory pathogens may indicate
a positive selection for BvlR consistent with its potential
role in infection in the niche environment of the lung
(Fig. S4).
BvlR is the first LTTR described in P. aeruginosa to
function predominantly as a transcriptional repressor. BvlR
fulfils a number of the ‘classical’ features associated with
LTTRs, such as the ability to negatively auto-regulate its
own expression, and to regulate expression of a divergently
transcribed gene, bvlA (Maddocks & Oyston, 2008; Schell,
1993). LTTRs are typically associated with positive trans-
criptional regulation of divergent targets. BvlR exhibits
an unusual mode of action in its regulation of BvlA, as it
negatively affects its expression. BvlR was found to bind
to the bvlR–bvlA intergenic region, specifically to the
TCCCGAATAGAGA motif, consistent with the classic
LTTR T-N11-A binding box (Parsek et al., 1994).
Additional complete BvlR binding motifs were not identified
in the P. aeruginosa genome sequence. This suggests that
redundancy may exist with some of the nucleotides within
the motif. Bioinformatic analysis identified a number of
partially conserved motifs within the P. aeruginosa genome
sequence. Of these potential binding targets, BvlR was shown
to directly bind to the sigX–oprF intergenic region. In spite
of the specific in vitro interaction between BvlR and
this promoter region, expression was not altered in the
mutant or complemented strain. This may be due to the
complex nature of oprF transcriptional regulation, with four
different promoters all having a significant impact on oprF
transcription with varying degrees of importance depending
on a range of environmental and metabolic conditions
(Bouffartigues et al., 2012). It is interesting to note that oprF
is upregulated in contact with sputum, and plays a crucial
role in the ability of P. aeruginosa to form tight micro-
colonies within ASM. Together, this suggests that a potential
regulatory interplay may exist between oprF and BvlR in
specific environments such as the CF lung. Outside of the
evidence presented of the bvlR–bvlR and sigX–oprF inter-
genic regions being direct binding targets for purified BvlR,
partially conserved BvlR binding motifs were also identified
upstream of a number of genes that were modulated in the
transcriptome, such as plcR, antA and coxB, suggesting these
may also be BvlR direct binding targets but only in the
presence of a ligand (Fig. S2). Future work will focus on
distinguishing the direct and indirect downstream regula-
tory pathways that are influenced by BvlR.
In agreement with the data from the molecular analysis
of BvlR, global transcriptome analysis highlighted the
potential role of BvlR as a transcriptional repressor, as it
was shown to downregulate the expression of its targets.
A number of transcriptional regulators were seen to be
modulated within the transcriptome dataset, although
searches of the available literature did not establish a
direct link between these regulators and the virulence
phenotypes associated with BvlR. Note, however, that BvlR
expression did repress the transcription of another
predicted LTTR, PA14_27400, and that phylogenetic
analysis of the evolution of LTTR proteins in P. aeruginosa
clustered both PA2877 and PA2838 (PA14_27400) together
in a single clade (Reen et al., 2013b). An interesting finding
in that paper was the interfacing of clustered regulatory
networks, suggesting that a novel regulatory cascade may
exist between these LTTRs. Future work will focus on the
potentially ligand-specific interaction of BvlR with other
transcriptional regulators that may underpin the virulence-
associated role of BvlR in P. aeruginosa.
The evidence presented highlights the significant impact
this previously uncharacterized regulator has in modulat-
ing the pathogenic potential of P. aeruginosa, significantly
influencing the production of acute virulence determinants
such as exotoxin A production and the T3SS. It is also
shown to have a significant impact on surface attachement
and a CF lung-specific mode of biofilm formation. The
influence that BvlR has on P. aeruginosa virulence is likely
to be the result of both direct and indirect effects and
further work is needed to define the hierarchical pathway
through which this key regulatory protein impacts on
virulence. However, taken together with the previous
observation of the upregulation of BvlR in response to
contact with epithelial cells (Frisk et al., 2004) the data
suggest that BvlR is a key component of the regulatory
interplay in the pathogen–host interactome.
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